Home » Newsletters » BioWorld

BioWorld

Feb. 3, 1998

View Archived Issues

Vertex Reports Positive Phase II Of HIV Protease Inhibitor

CellPro's Stock Surges On Court Victory In Patent Fight

Other News To Note

U.S. Patent Disclosures

Feinstein, Kennedy Offer Bill To Ban Human Cloning

SmithKline, Glaxo Wellcome In 'Detailed' Merger Talks; Deal Worth Up To $70B

Roche To Pay DeCode $200M For Disease Gene Discovery

Los Alamos Tests Method To Detect Bacillus Anthracis In Tissue Samples

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026